Randomized phase 2 trial of pemetrexed, pemetrexed/bevacizumab, and pemetrexed/carboplatin/bevacizumab in patients with stage IIIB/IV non-small cell lung cancer and an Eastern Cooperative Oncology Group performance status of 2. - Spigel, David R.; Hainsworth, John D.; Joseph, Mathew J.; Shipley, Dianna L.; Hagan, M. Kelly; Thompson, Dana S.; Burris, III, Howard A.; Greco, F. Anthony; Burris, Howard A 3rd (Cancer (0008543X), 2018)